MedPath

MYRBETRIQ

MYRBETRIQ

Approved
DIN Number

02402882

Drug Class

Human

Market Date

Mar 28, 2013

Company
HC

astellas pharma canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02402882
AIG Number0154130002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G04BD URINARY ANTISPASMODICS
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification86:12.08.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

MIRABEGRONActive
Strength: 50 MG
Monograph: MIRABEGRON

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.